Cardiovascular Outcomes - Phoenix AZ

Clinical Trial 64964

Phoenix, AZ 85018

Summary:

A Phase III double-blind, randomised, parallel-group superiority

trial to evaluate efficacy and safety of the combined use of oral

study medication and empagliflozin compared with

placebo and empagliflozin in participants with type 2 diabetes,

hypertension and established cardiovascular disease 

Qualified Participants Must:

• Be at least 18 years old
• Have medical history of HTN, T2DM, CV disease without having had a heart attack less than three months from screening
• Can not have been diagnosed with heart failure

Qualified Participants May Receive:

Compensation for time/travel and consultation with Physician

Available At:

Elite Clinical Studies
4520 E Indian School Rd
Phoenix, AZ 85018
View Clinic Location

 

If you or someone you care for is interested in participating and lives within 50 miles of the location shown, please complete the form below and click 'Submit'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.



© 1998-2025 | All trademarks are property of their legal owners. | All Rights Reserved

ClinicalConnection is a resource that provides information on clinical trials and other research opportunities worldwide.

ClinicalConnection does not conduct or endorse this research. Please consult your physician before participating.

Latest Blog Posts

Useful Links

Contact Us

75 Second Ave, Suite 605
Needham, MA 02494
1-800-887-0639
info@clinicalconnection.com
Click here to contact us

1998-2025 © All Rights Reserved. Privacy Policy | Terms of Service